|
 |
| home > ict > Winter 2008 |
|
|
 PUBLICATIONS |
International Clinical Trials |
|
|
|
|
| At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. ICT provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of pharmaceuticals, take a look below at the range of articles featured in this issue of ICT |
 |
| |
|
|
|
| As the pharma industry struggles to cope with the high rate of Phase III failures, Mike Macnamee of LCG Bioscience believes that it is crucial to use patients in the early stages of clinical research in order to grasp the opportunities created by more personalised and gene-specific therapeutics, in Patients Are a Virtue |
|
|
| Kenneth Getz at the Tufts Center for the Study of Drug Development, James Kremidas at Eli Lilly and Company, Elizabeth Carfioli of Ogilvy Healthworld Consulting (US) and Rachael Butlin at Fast4wD Ogilvy (UK) pursue ways in which to challenge and improve public perceptions of clinical research, in We Can be Heroes |
|
|
| In New Waves, Dr Timothy Callahan and Dr Pierre Maison-Blanche of Biomedical Systems put the spotlight on comprehensive training at investigative sites – a necessary step for ensuring that ECG data collected onsite is of a high quality, free of artifact and has minimal variability |
|
|
| Bruce Stouch at Premier Research explores the construct of asymmetrical boundaries for interim monitoring of a fixed design, as well as the design requirements for monitoring using a Bayesian approach, in Monitored Progress |
|
|
|
| Secure, private and of higher quality than paper diary records, eDiaries have finally entered the mainstream. In Regulating e-Diaries, Valdo Arnera and Stephen A Raymond of PHT Corporation reflect on the key regulations affecting eDiary systems and how their providers and sponsors should adhere to these rules |
|
|
| In Pharma Champion, Mark Penniston at Omnicare Clinical Research General notes that acceptance of CDISC has gained momentum over the past few years and has a very strong future, especially as regulatory bodies increase their usage of these standards |
|
|
| Clinical trials frequently rely on subjective clinician-rated outcomes as pivotal endpoints – thus missing out on electronic tools which can assist in reinforcing continuous data reliability. In Improving Ratings Precision, Oto Markovic and Rusty Bealer of United BioSource Corporation examine how these systems can be designed and deployed in support of clinical trials |
|
|
|
|
| In The Power of Communication, Mark Woolf of Almac Clinical Services explores the complex challenges faced by distribution managers surrounding the shipping of clinical trials materials to emerging markets |
|
|
| The temperature-sensitive nature of numerous drugs and the importance of achieving reliable test results make it particularly important that drugs arrive at their destination with their integrity intact. Geraint Thomas of Laminar Medica points to the advantages of careful planning and investment in the latest technology during shipping, in The Trials of Temperature Control |
|
|
|
| Over the past year revenues from global clinical trials have increased by almost 15 per cent. Gary Muddyman of Conversis unpicks the Cultural Dimensions of running trials in emerging markets, outlining the need to avoid stumbling blocks such as differing clinical trial demands in disparate locales, varied sales and distribution channels, the coordination of simultaneous launches to market, and drug cloning and counterfeiting |
|
|
| Having overcome a recent spot of trouble, Russia’s role in the development of international clinical trials in Central and Eastern Europe looks increasingly promising; whilst the emergence of Ukraine, Belarus and Kazakhstan in the trials arena in 2008 will be one to watch out for, opines Irina Dobreva of Congenix in Research Reaches Beyond Borders |
|
|
| Shifting pharmacovigilance and clinical data management work abroad is allowing pharmaceutical firms to maximise R&D and push drugs to market more effectively – Charles Arnold and Vicki Tauscher Phelan of EquaTerra investigate The New Frontier in outsourcing |
|
|
|
|
|
 |
|
|
 |
Industry Events |
 |
Exploratory Clinical Development World Americas 2008
23-25 September 2008, Philadelphia Marriott Downtown, 1201 Market Street, Philadelphia, Pennsylvania, 19107 USA
Following on from the huge success of the Exploratory
Clinical Development World Europe, the Americas
congress will give you a critical insight into the latest strategies on how the
industry is addressing and elevating the current challenges in early clinical
development.
More info >> |
|
 |
News and Press Releases |
 |
Azopharma Product Development Group, Inc
HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today the addition of innovative state-of-the-art equipment at its formulation and manufacturing division, ApiCross Drug Delivery Technologies in Hollywood, Florida. The most recent acquisition is the MG Futura Capsule Filler which delivers the latest in capsule filling technology. The company has also added a Bausch & Strobel Aseptic Filling Isolator, equipment that is ground-breaking in the powder filling process. These additions support our previously implemented XcelodoseTM powder micro-dosing system. With these technologies, Azopharma is able to provide its clients with all forms of the capsule filling process. The new equipment is part of Azopharma’s recent manufacturing expansion which includes 17 new manufacturing suites for GMP, cytotoxic and aseptic products...
More info >> |
|
__________________________
__________________________
__________________________
__________________________
|
